Analysis of Key Market Segments Driving the Rat Model Market

The rat model market is gaining significant traction as research and development efforts intensify in biomedical and pharmaceutical fields. With advancements in genetic editing and precision medicine, the demand for sophisticated rat models to study human diseases is rising rapidly. Below, we explore the market's anticipated growth, key players, prevailing trends, and segmentation details.

Projected Market Size and Growth Trajectory of the Rat Model Market
The rat model market is poised for considerable expansion, expected to reach a valuation of $2.8 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 9.9%. Factors driving this increase include a surge in investments targeting precision medicine research, heightened demand for predictive disease models, and the growing application of gene-editing techniques. Moreover, efforts to lower clinical trial failure rates and the widespread adoption of humanized rat platforms also contribute to this upward trend. Key trends shaping the market involve the rising use of CRISPR-based rat models, greater demand for immunodeficient and humanized rats, expanding preclinical disease modeling, advancements in genetic editing technologies, and a stronger emphasis on translational research accuracy.

Download a free sample of the rat model market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10100&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Market Players Driving Innovation in Rat Models
Several prominent companies dominate the rat model market landscape, including Genoway SA, Charles River Laboratories International Inc, Taconic Biosciences Inc, Envigo Ltd, Janvier Labs, Harlan Laboratories Inc, Cyagen Biosciences Inc, Ozgene Pty Ltd, Beijing Biocytogen Co Ltd, Ingenious Targeting Laboratory, Mirimus Inc, Pharmaron Beijing Co Ltd, PolyGene AG, Shanghai Model Organisms Center Inc, Transgenic Inc, Viva Biotech Holdings, WuXi AppTec Co Ltd, Applied StemCell Inc, Transviragen Inc, Biomere, Laboratory Corporation of America Holdings, Horizon Discovery Group PLC, Synthego Corporation, and ViGene Biosciences Inc.
In a notable development, Denmark-based Scantox A/S expanded its capabilities in preclinical pharmacology by acquiring QPS Austria GmbH in November 2023. This acquisition, with undisclosed financial terms, aims to bolster drug discovery efforts especially for neurodegenerative, rare, and mental diseases. QPS Austria GmbH is recognized for its contract research services focusing on rat model applications.

Emerging Trends That Are Positively Impacting Rat Model Market Growth
A growing focus among leading companies and preclinical organizations is the development of specialized nephropathy animal models. These models are designed to more accurately replicate human kidney diseases, facilitating faster drug discovery and therapeutic research. Nephropathy models provide a controlled environment for understanding renal dysfunction, injury, and treatment effectiveness.
For example, in October 2024, Physiogenex, a preclinical research firm based in France, introduced a novel IgA nephropathy rat model. Unveiled at ASN Kidney Week, this model displays critical characteristics of IgA nephropathy such as mesangial IgA deposits and proteinuria, offering researchers a reliable platform for translational studies and advancing targeted kidney disease treatments.

View the full rat model market report:
https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Comprehensive Segmentation Overview of the Rat Model Market
This report segments the rat model market into several categories as follows:
1) By Type: Knockout, Outbred, Inbre*d, Hybrid, Immunodeficient, and Conditioned models
2) By Service: Cryopreservation, Breeding, Re-derivation, and Genetic Testing services
3) By Application: Oncology, Neurology, Immunology, Toxicology, and other research applications

Further subcategories include:
- Knockout models divided into CRISPR Knockout and Traditional Knockout
- Outbred strains such as Sprague Dawley, Long-Evans, and Wistar
- Inbre*d strains including Fischer 344, Lewis, and Buffalo
- Hybrid types covering F1 Hybrid and F2 Hybrid
- Immunodeficient rats like Nud*e Rats and SCID Rats
- Conditioned rats comprising Obese Rats and Diabetic Rats

These diverse segments reflect the broad utility and specialization within the rat model market, supporting a wide array of scientific research needs.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.